Indoor air pollutants in schools: Nasal patency and biomarkers in nasal lavage

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 2, 2000, Pages 163-170

  Norbäck, Dan ^a   Walinder R ^a   Wieslander, G ^a   Smedje, G ^a   Erwall, C ^a   Venge, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acoustic rhinometry; Albumin; Eosinophil cationic protein (ECP); Formaldehyde; Indoor air quality; Lysozyme; Nasal lavage; Nitrogen dioxide; Respirable dust; School environment

Indexed keywords

ALBUMIN; CARBON DIOXIDE; EOSINOPHIL CATIONIC PROTEIN; LYSOZYME; NITROGEN DIOXIDE;

AIR CONDITIONING; AIR POLLUTANT; AMBIENT AIR; ARTICLE; ASTHMA; HUMAN; LAVAGE; MAJOR CLINICAL STUDY; NOSE; PRIORITY JOURNAL; RHINOMETRY; SCHOOL; SCHOOL CHILD;

AIR POLLUTANTS; AIR POLLUTION, INDOOR; ALBUMINS; BLOOD PROTEINS; CROSS-SECTIONAL STUDIES; EOSINOPHIL GRANULE PROTEINS; HUMANS; INFLAMMATION MEDIATORS; MIDDLE AGED; MURAMIDASE; NASAL CAVITY; NASAL LAVAGE FLUID; PEROXIDASE; PULMONARY VENTILATION; RIBONUCLEASES; SCHOOLS; SWEDEN;

EID: 0033953706     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00353.x     Document Type: Article

References (48)

1. 1. MUNIR AKM, EINARSSON R, SCHOU C. Allergens in school dust. I. The amount of the major cat (Fel d I) and dog (Can f I) allergens in dust from Swedish schools is high enough to probably cause perennial symptoms in most children with asthma who are sensitized to cat and dog. J Allergy Clin Immunol 1993;91:1067-1074.
2. 2. SMEDJE G, NORBÄCK D, EDLING C. Asthma among secondary school pupils in relation to the school environment. Clin Exp Allergy 1997;27:1270-1278.
3. 3. SMEDJE G, NORBÄCK D. New ventilation systems at selected schools in Sweden effects on asthma and exposure. Arch Environ Health 2000 (in press).
4. 4. TASKINEN T, MEKLIN T, NOUSIAINEN M, HUSMAN T, NEVALAINEN A, KORPPI M. Moisture and mould problems in schools and respiratory manifestations in schoolchildren: clinical and skin test findings. Acta Paediatr 1997;86:1181-1187.
5. 5. COOLEY JD, WONG WC, JUMPER CA, STRAUS DC. Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med 1998;55:579-584.
6. 6. DAHLQVIST M, ALEXANDERSSON R. Acute pulmonary function impairment in a school staff working in a "sick building": a pilot study. Indoor Environ 1992;2:179-185.
7. 7. NORBÄCK D, TORGEN M, EDLING C. Volatile organic compounds, respirable dust and personal factors related to prevalence and incidence of sick building syndrome in primary schools. Br J Ind Med 1990;47:733-741.
8. 8. NEUBERGER JS, NEWKIRK DD, COTTER J, THORPE A, WOOD C, IRWIN JC. Diminished air quality and health problems in a Kansas City, Kansas, elementary school. J Sch Health 1991;61:439-442.
9. 9. RUOTSALAIENEN R, TEIJONSALO J, SEPPÄNEN O. Ventilation and indoor air quality in Finnish schools. In: FLATHEIM G, BERG KR, EDVARDSEN K, editors. Indoor air quality in practice - moisture and cold climate solutions. Oslo: Norwegian Society of Chartered Engineers, 1995:489-493.
10. 10. WILLERS S, ANDERSSON S, ANDERSSON R, GRANTEN J, SVERDRUP C, ROSELL L. Sick building syndrome symptoms among the staff in schools and kindergartens: are levels of volatile organic compounds and carbon dioxide responsible? Indoor Built Environ 1996;5:232-235.
11. 11. SMEDJE G, NORBÄCK D, EDLING C. Subjective indoor air quality in schools in relation to exposure. Indoor Air 1997;7:143-150.
12. 12. National Swedish Board of Occupational Safety and Health. Ventilation and quality of air. AFS 1993: 5, Stockholm, 1993 [in Swedish].
13. 13. RŌNNMARK E, PERZANOWSKI M, LUNDBÄCK B, PLATTS-MILLS TAE. High levels of cat and dog allergens in the working environment in schools in northern Sweden, and allergic sensitization. In: CHIYOTANI K, HOSADA Y, AIZAWA Y, editors. Advances in the prevention of occupational respiratory diseases. Medica International Congress Series 1153. Amsterdam: Elsevier, 1998:424-429.
14. 14. JESSEN M, MALM L. Definition, prevalence and development of nasal obstruction. Allergy 1997;52 Suppl 40:3-6.
15. 15. WÅLINDER R, NORBÄCK D, WIESLANDER G, SMEDJE G, ERWALL C, VENGE P. Nasal patency and biomarkers in nasal lavage the significance of air exchange rate and type of ventilation in schools. Int Arch Occup Environ Health 1998;71:479-486.
16. 16. KOREN HS, HATCH GE, GRAHAM ED. Nasal lavage as a tool in assessing acute inflammation in response to inhaled pollutants. Toxicology 1990;60:15-25.
17. 17. PEDEN DB. The use of nasal lavage for objective measurement of irritant-induced nasal inflammation. Regul Toxicol Pharmacol 1996;24:76-78.
18. 18. PIPKORN N, KARLSSON G, ENERBÄCK L. Nasal mucosal response to repeated challenges with pollen allergen. Am Rev Respir Dis 1989;140:729-736.
19. 19. RAPHAEL GD, JENEY EV, BARANIUK JN, KIM I, MEREDITH SD, KALINER MA. Pathophysiology of rhinitis, lactoferrin and lysozyme in nasal secretions. Clin Invest 1989;84:1528-1535.
20. 20. WÅLINDER R, NORBÄCK D, WIESLANDER G, SMEDJE G, ERWALL C, VENGE P. Nasal patency and lavage biomarkers in relation to settled dust and cleaning routines in schools. Scand J Work Environ Health 1999;25:137-143.
21. 21. WANG JH, DEVALIA JL, DUDDLE JM, HAMILTON SA, DAVIES RJ. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:669 676.
22. 22. PAZDRAK K, GORSKI P, KRAKOWIAK A, RUTA U. Changes in nasal lavage fluid due to formaldehyde inhalation. Int Arch Occup Environ Health 1993;64:515-519.
23. 23. ANDERSSON K, HALLGREN C, LEVIN J-O, NILSSON C-A. Chemosorption sampling and analysis of formaldehyde in air: influence on recovery during simultaneous sampling of formaldehyde, phenol, furfural alcohol. Scand J Work Environ Health 1981;7:282-289.
24. 24. PALMGREN U, STRÖM G, BLOMQVIST G, MALMBERG P. Collection of airborne microorganisms on nucleopore filters, estimation and analysis - CAMNEA method. J Appl Bacteriol 1986;61:401-406.
25. 2 badge: (I) in indoor environments. Indoor Air 1993;3:124-130.
26. 26. VENGE P, HÄLLGREN R, STÅLENHEIM G, OLSSON I. Effects of serum and cations on the selective release of granular proteins from human neutrophils during phagocytosis. Scand J Haematol 1979;22:317-326.
27. 27. PETERSON CGB, NYSTRAND J, ANDERSSON AS, NILSSON L, VENGE P. Radioimmunoassay of human eosinophil cationic protein by an improved method. Establishment of normal levels in serum turnover in vivo. Clin Exp Allergy 1991;21:561-567.
28. 28. SCHMEKEL B, KARLSSON SE, LINDEN K, SUNDSTRÖM C, TEGNER H, VENGE P. Myeloperoxidase in human lung lavage. I. A marker of local neutrophils during phagocytosis. Inflammation 1990; 14:447-454.
29. 29. GREBSKI V, LEUNG O, MCNEIL D, LUNN D. SPIDA user's manual, version 6. Statistical Computing Laboratory, Eastwood, Australia, 1992.
30. 30. WIESLANDER G, NORBÄCK D, WÅLINDER R, ERWALL C, VENGE P. Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study. Int Arch Occup Environ Health 1999;72:507-515.
31. 31. WIESLANDER G, NORBÄCK D, NORDSTRÖM K, WÅLINDER R, VENGE P. Nasal and ocular symptoms, tear film stability, and biomarkers in nasal lavage, in relation to building dampness and building design in hospitals. Int Arch Occup Environ Health 1999;72:451-461.
32. 32. REINIKAINEN LM, JAAKOLA JJK, SEPPÄNEN O. The effect of air humidification on symptoms and perception of indoor air quality in office workers: a six-period cross-over trial. Arch Environ Health 1992;47:8-15.
33. 33. NORDSTRÖM K, NORBÄCK D, AKSELSSON R. The effect of humidification on the sick building syndrome and perceived indoor air quality in hospitals. A four months' longitudinal study. Occup Environ Med 1994;51:683-688.
34. 34. WANTKE F, DEMMER CM, TAPPLER P, GÖTZ M, JARISCH R. Exposure to gaseous formaldehyde induces IgE-mediated sensitization to formaldehyde in schoolchildren. Clin Exp Allergy 1996;26:276-280.
35. 35. NORBÄCK D, BJÖRNSSON E, JANSON C, WIDSTRÖM J, BOMAN G. Asthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings. Occup Environ Med 1995;52:388-395.
36. 36. WOLKOFF P, CLAUSEN PA, JENSEN B, NIELSEN GD, WILKINS CK. Are we measuring the relevant indoor pollutants? Indoor Air 1997;7:92-106.
37. 37. WICKMAN M, EGMAR A-C, EMENIUS G, et al. Fel d 1 and Can f 1 in settled dust and airborne Fel d 1 in allergen avoidance day-care centres for atopic children in relation to number of pet-owners, ventilation and general cleaning. Clin Exp Allergy 1999;29:626-632.
38. 38. HOLMBERG K. Indoor mould exposure and health effects. In: SEIFERT B, ESDORN H, FISCHER M, RUDEN H, WEGNER J, editors. Indoor Air '87. Vol. 1. Berlin: Institute for Water, Soil and Air Hygiene, 1987:637-642.
39. 39. PIECKOVA E, JESENSKA Z. Microscopical fungi in dwellings and their health implications in humans. Ann Agric Environ Med 1999;6:1-11.
40. 40. SAVOLAINEN J, KORTEKANGAS-SAVOLAINEN O, NERMES M, et al. IgE, IgA and IgG responses to common yeasts in atopic patients. Allergy 1998;53:506-512.
41. 41. LI C-S, HSU L-Y. Airborne fungus allergen in association with residential characteristics in atopic and control children in a subtropical region. Arch Environ Health 1997;52:72-79.
42. 42. BJÖRNSSON E, NORBÄCK D, JANSON C, et al. Asthmatic symptoms and indoor levels of microorganisms and house dust mites. Clin Exp Allergy 1995;25:423-431.
43. 43. HOLT PG, MACAUBAS C, PRESCOTT SL, SLY PD. Microbial stimulation as an aetiological factor in atopic disease. Allergy 1999;54 Suppl 49:6-12.
44. 44. HORNER WE, HELBLING A, SALVAGGIO JE, LEHRER SB. Fungal allergens. Clin Microbiol Rev 1995;8:161-179.
45. 45. NORBÄCK D, BJÖRNSSON E, JANSON C, BOMAN G. Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings. Int J Tuberc Lung Dis 1999;3:368-376.
46. 46. FLANNIGAN B, MILLER D. Health implications of fungi in indoor environments an overview. In: SAMSON RA, FLANNIGAN B, FLANNIGAN ME, VERHOEFF AP, ADAN OCG, HOEKSTRA ES, editors. Health implications of fungi in indoor environments. Air Quality Monographs. Vol. 2. Amsterdam: Elsevier, 1994:3-28.
47. 47. VENGE P, HÁKANSSON L, PETERSON CGB. Eosinophil activation in allergic disease. Int Arch Allergy Appl Immunol 1989;2:333-237.
48. 48. RAPHAEL GD, JENEY EV, BARANIUK JN, KIM I, MEREDITH SD, KALINDER MA. Pathophysiology of rhinitis, lactoferrin and lysozyme in nasal secretions. Clin Invest 1989;84:1528-1535.